1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Chongqing Xishan Science and Technology Co., Ltd. Class A

Chongqing Xishan Science and Technology Co., Ltd. Class A

SSSE:688576
36.50
CNY
-0.40
(-1.08%)
2.70BMarket Cap
Oct 31Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.84
3.73
1.04
2.25
1.79
2.75
3.81
4.44
5.22
4.51
5.08
- -
Basic EPS, GAAP
-0.08
-0.78
-0.05
0.59
-1.17
0.31
1.12
1.28
1.7
1.32
0.77
- -
Free Cash Flow per Basic Share
-0.77
-1.63
-0.15
0.53
-0.87
0.71
0.76
0.51
-0.52
-1.58
-0.53
- -
Dividend per Share
- -
0.04
0.02
0.01
0.03
0.04
- -
- -
- -
0.66
0.67
-0.01
Book Value per Share
0.63
0.48
0.68
1.25
-0.35
1.95
5.5
6.86
27.36
23.87
25.49
24.88
Tangible Book Value per Share
0.63
0.48
0.52
1.08
-0.51
1.82
5.49
6.55
27.1
23.57
25.17
24.58
Basic Weighted Avg Shares
9
9
41
45
46
46
55
59
69
75
67
67
Sales/Revenue/Turnover
42
33
43
101
82
127
209
262
361
336
342
- -
Operating Margin (%)
-7.47
-31.35
-15.56
15.9
-51.47
13.85
26.5
26.74
30.28
22.38
11.79
- -
Depreciation Expense
1
1
2
2
4
4
8
9
11
14
26
- -
Net Income, GAAP
-1
-7
-2
26
-54
14
61
75
117
99
52
- -
Effective Tax Rate (%)
- -
- -
- -
11.19
- -
- -
- -
- -
7.65
11.4
2.22
- -
Profit Margin (%)
-1.66
-20.85
-4.52
26.25
-65.7
11.14
29.41
28.73
32.53
29.33
15.18
- -
Working Capital
24
5
14
40
-43
79
296
299
1,566
1,005
1,290
1,238
LT Debt
- -
- -
- -
- -
- -
8
6
2
- -
- -
- -
- -
Total Equity
29
22
31
58
-16
103
326
406
2,161
1,765
1,728
1,683
Return on Invested Capital (%)
- -
- -
- -
23.41
- -
- -
- -
- -
9.03
5
2.98
- -
Return on Capital (%)
- -
- -
- -
48.41
- -
- -
- -
- -
9.12
5.02
2.97
- -
Return on Common Equity (%)
- -
-26.82
-7.19
59.27
- -
- -
28.63
20.58
9.14
5.03
2.97
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
68
68
68
Market Capitalization
2,865
3,097
2,696

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,453
1,423
1,353
Cash, Cash Equivalents & STI
725
695
623
Accounts Receivable, Net
39
37
34
Inventories
134
139
139
Total Current Liabilities
163
134
114
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-10.97%
130.14%
-2.1%
Free Cash Flow
-93.01%
-11.85%
-69.55%
Net Income, GAAP
-74.19%
69.59%
-47.39%
Sales/Revenue/Turnover
30.13%
24.4%
1.67%
Total Cash Common Dividend
- -
- -
-7.56%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
74
77
56
129
336
2025
66
89
- -
111
342
2026
72
48
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.33
0.42
0.1
0.46
1.32
2025
0.15
0.34
- -
0.13
0.77
2026
0.11
-0.49
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.66
2025
- -
- -
- -
-0.01
0.67
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yi Jun Guo
Full Time Employees
695
Sector
Health technology
Industry
Medical specialties
Address
Chongqing China
IPO Date
Jun 6, 2023
Website
xishantech.com.cn
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Chongqing Xishan Science and Technology Co., Ltd. is a China-based medical technology company that specializes in the research, development, manufacture, and commercialization of minimally invasive surgical power devices, endoscopic visualization systems, and energy-based surgical instruments. Founded in 1999 and headquartered in Chongqing, China, the company operates across several primary product segments, including surgical power devices and specialized consumables; 4K ultra-high-definition and fluorescence endoscopic imaging systems; energy surgical platforms including ultrasonic cutting and hemostatic systems; and vacuum-assisted breast biopsy and excision systems. Its surgical power portfolio comprises electronic control consoles, motor handpieces, craniotomes, high-speed bone drills, sagittal and oscillating saws, micro-shavers, and a comprehensive range of disposable and reusable cutting tools such as surgical burs, drill bits, saw blades, and milling cutters utilized in neurosurgery, orthopedics, spinal surgery, otorhinolaryngology, and craniomaxillofacial surgery. The company also manufactures rigid laparoscopes, arthroscopes, sinusoscopes, LED cold light sources, medical insufflators, ultrasonic surgical scalpel generators, and transducers for minimally invasive soft tissue management. Chongqing Xishan Science and Technology distributes its medical devices to hospitals across China and exports to international markets across Europe, Latin America, Southeast Asia, the Middle East, and Africa. Following its public listing on the Shanghai Stock Exchange Science and Technology Innovation Board under ticker 688576, the company has expanded its manufacturing and R&D facilities, broadened international product registrations and export channels, advanced next-generation intelligent power systems and 4K fluorescence imaging platforms, and established clinical partnerships to accelerate the adoption of its surgical technologies.